Axa Buys Shares of 30,000 Israel Chemicals Ltd (ICL)

Axa bought a new stake in Israel Chemicals Ltd (NYSE:ICL) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 30,000 shares of the basic materials company’s stock, valued at approximately $181,000.

Several other institutional investors also recently modified their holdings of ICL. Eqis Capital Management Inc. bought a new position in shares of Israel Chemicals during the 2nd quarter worth about $245,000. Aperio Group LLC lifted its holdings in shares of Israel Chemicals by 64.3% during the 2nd quarter. Aperio Group LLC now owns 338,704 shares of the basic materials company’s stock worth $1,558,000 after acquiring an additional 132,608 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Israel Chemicals by 29.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 144,534 shares of the basic materials company’s stock worth $659,000 after acquiring an additional 33,274 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its holdings in Israel Chemicals by 2,050.6% during the 2nd quarter. Clal Insurance Enterprises Holdings Ltd now owns 649,982 shares of the basic materials company’s stock valued at $2,990,000 after purchasing an additional 619,759 shares during the last quarter. Finally, Swiss National Bank lifted its holdings in Israel Chemicals by 2.7% during the 2nd quarter. Swiss National Bank now owns 2,652,169 shares of the basic materials company’s stock valued at $12,117,000 after purchasing an additional 70,216 shares during the last quarter. Institutional investors and hedge funds own 9.19% of the company’s stock.

Several equities analysts recently issued reports on the stock. BMO Capital Markets reissued a “hold” rating and set a $5.25 price target on shares of Israel Chemicals in a report on Wednesday, September 19th. Zacks Investment Research raised shares of Israel Chemicals from a “sell” rating to a “hold” rating in a report on Wednesday, August 29th. ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a report on Friday, August 24th. Finally, Jefferies Financial Group reissued a “hold” rating and set a $6.57 price target on shares of Israel Chemicals in a report on Sunday, October 21st. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $5.69.

Shares of ICL stock opened at $5.61 on Monday. Israel Chemicals Ltd has a 12-month low of $3.85 and a 12-month high of $6.90. The stock has a market cap of $7.31 billion, a P/E ratio of 18.10, a PEG ratio of 1.60 and a beta of 1.08. The company has a quick ratio of 0.73, a current ratio of 1.34 and a debt-to-equity ratio of 0.44.

Israel Chemicals (NYSE:ICL) last announced its quarterly earnings results on Thursday, November 1st. The basic materials company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.01. Israel Chemicals had a net margin of 23.84% and a return on equity of 13.67%. The firm had revenue of $1.37 billion during the quarter, compared to the consensus estimate of $1.38 billion. During the same period last year, the firm posted $0.09 EPS. The firm’s quarterly revenue was down 4.8% on a year-over-year basis. On average, equities research analysts expect that Israel Chemicals Ltd will post 0.37 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 19th. Investors of record on Tuesday, December 4th will be issued a dividend of $0.051 per share. This is an increase from Israel Chemicals’s previous quarterly dividend of $0.04. This represents a $0.20 annualized dividend and a yield of 3.64%. The ex-dividend date of this dividend is Monday, December 3rd. Israel Chemicals’s dividend payout ratio (DPR) is currently 16.13%.

TRADEMARK VIOLATION WARNING: This report was first posted by WKRB News and is the property of of WKRB News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.wkrb13.com/2018/12/10/axa-buys-shares-of-30000-israel-chemicals-ltd-icl.html.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Read More: Determine Your Level of Risk Tolerance

Want to see what other hedge funds are holding ICL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Israel Chemicals Ltd (NYSE:ICL).

Institutional Ownership by Quarter for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply